MA27986A1 - Inhibiteurs de kinesine mitotique - Google Patents

Inhibiteurs de kinesine mitotique

Info

Publication number
MA27986A1
MA27986A1 MA28785A MA28785A MA27986A1 MA 27986 A1 MA27986 A1 MA 27986A1 MA 28785 A MA28785 A MA 28785A MA 28785 A MA28785 A MA 28785A MA 27986 A1 MA27986 A1 MA 27986A1
Authority
MA
Morocco
Prior art keywords
inhibitors
mitotic kinesin
dna
sequence
fully synthetic
Prior art date
Application number
MA28785A
Other languages
English (en)
Inventor
Paul J Coleman
Christopher D Cox
Robert M Garbaccio
George D Hartman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MA27986A1 publication Critical patent/MA27986A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Structural Engineering (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

LISTAGE DE SEQUENCE <110> Merck & Co., Inc. Coleman, Paul J. Cox, Christopher D. Garbaccio, Robert M. Hartman, George D. <12Û> INHIBITEURS DE KINESINE MITOTIQUE <130> 21481YS <I60> 2 <170> FastSEQ pour Windows Version 4.0 <210> 1 <211> 42 <212> ADN <213> Séquence artificielle <220> <223> Séquence de nucléotides entièrement synthétique <400> 1 gcaacgatta atatggcgtc gcagccaaat tcgtctgcga ag 42 <210> 2 <211> 60 <212> ADN <213> Séquence artificielle <220> <223> Séquence de nucléotides entièrement synthétique <400> 2 gcaacgctcg agtcagtgat gatggtggtg atgctgattc acttcaggct tattcaatat 60
MA28785A 2003-08-15 2006-02-08 Inhibiteurs de kinesine mitotique MA27986A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49563703P 2003-08-15 2003-08-15
US51268003P 2003-10-20 2003-10-20
US56358604P 2004-04-19 2004-04-19

Publications (1)

Publication Number Publication Date
MA27986A1 true MA27986A1 (fr) 2006-07-03

Family

ID=34222358

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28785A MA27986A1 (fr) 2003-08-15 2006-02-08 Inhibiteurs de kinesine mitotique

Country Status (13)

Country Link
US (1) US20050038074A1 (fr)
KR (1) KR20060058716A (fr)
AR (1) AR045342A1 (fr)
BR (1) BRPI0413580A (fr)
CO (1) CO5650252A2 (fr)
EC (1) ECSP066362A (fr)
IL (1) IL173513A0 (fr)
IS (1) IS8276A (fr)
MA (1) MA27986A1 (fr)
NO (1) NO20061194L (fr)
PE (1) PE20050730A1 (fr)
TW (1) TW200510380A (fr)
WO (1) WO2005019205A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050010515A (ko) 2002-06-14 2005-01-27 머크 앤드 캄파니 인코포레이티드 유사분열 키네신 억제제
US7301028B2 (en) 2002-06-14 2007-11-27 Merck & Co., Inc. Mitotic kinesin inhibitors
WO2005018547A2 (fr) 2003-08-15 2005-03-03 Merck & Co., Inc. Inhibiteurs de kinesine mitotique
JP2007502775A (ja) 2003-08-15 2007-02-15 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害剤
DE602004019229D1 (de) * 2003-08-15 2009-03-12 Merck & Co Inc Inhibitoren von mitotischem kinesin
US20070225499A1 (en) * 2004-04-19 2007-09-27 Gary Javadi Process for the Preparation of 2,2-Disubstituted Pyrroles
EP1888050B1 (fr) 2005-05-17 2012-03-21 Merck Sharp & Dohme Ltd. Acide cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl) cyclohexanepropanoique pour le traitement du cancer
CA2645137A1 (fr) * 2006-03-07 2007-09-13 James F. Blake Derives heterobicycliques de pyrazole et methodes d'utilisation
US8796460B2 (en) 2007-10-19 2014-08-05 Mercky Sharp & Dohme Corp. Compounds for inhibiting KSP kinesin activity
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
EP2488028B1 (fr) 2009-10-14 2020-08-19 Merck Sharp & Dohme Corp. Pipéridines substituées qui accroissent l'activité de p53 et utilisations de ces composés
WO2011163330A1 (fr) 2010-06-24 2011-12-29 Merck Sharp & Dohme Corp. Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk
CN107090456B (zh) 2010-08-02 2022-01-18 瑟纳治疗公司 使用短干扰核酸的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1基因表达的抑制
JP2013537423A (ja) 2010-08-17 2013-10-03 メルク・シャープ・エンド・ドーム・コーポレイション 低分子干渉核酸（ｓｉＮＡ）を用いたＢ型肝炎ウイルス（ＨＢＶ）遺伝子発現のＲＮＡ干渉媒介性阻害
WO2012030685A2 (fr) 2010-09-01 2012-03-08 Schering Corporation Dérivés d'indazole utilisables en tant qu'inhibiteurs de la voie erk
DK2632472T3 (en) 2010-10-29 2018-03-19 Sirna Therapeutics Inc RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA)
WO2012087772A1 (fr) 2010-12-21 2012-06-28 Schering Corporation Dérivés d'indazole utiles en tant qu'inhibiteurs de erk
WO2013063214A1 (fr) 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Nouveaux composés qui sont des inhibiteurs d'erk
EP2844261B1 (fr) 2012-05-02 2018-10-17 Sirna Therapeutics, Inc. Compositions de petit acide nucléique interférent (sina)
CN105050598B (zh) 2012-09-28 2018-04-27 默沙东公司 作为erk抑制剂的新型化合物
RS56680B1 (sr) 2012-11-28 2018-03-30 Merck Sharp & Dohme Kompozicije i postupci za lečenje kancera
US8846657B2 (en) 2012-12-20 2014-09-30 Merck Sharp & Dohme Corp. Substituted imidazopyridines as HDM2 inhibitors
WO2014120748A1 (fr) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. Purines 2,6,7,8-substituées utilisées en tant qu'inhibiteurs de hdm2
EP3041938A1 (fr) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Polynucléotides circulaires
JOP20190055A1 (ar) 2016-09-26 2019-03-24 Merck Sharp & Dohme أجسام مضادة ضد cd27
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
MX2019012233A (es) 2017-04-13 2020-01-14 Aduro Biotech Holdings Europe Bv Anticuerpos anti-sirpa.
EP3706742B1 (fr) 2017-11-08 2023-03-15 Merck Sharp & Dohme LLC Inhibiteurs de prmt5
US11098059B2 (en) 2017-11-08 2021-08-24 Merck Sharp & Dohme Corp. PRMT5 inhibitors
WO2019148412A1 (fr) 2018-02-01 2019-08-08 Merck Sharp & Dohme Corp. Anticorps bispécifiques anti-pd-1/lag3
EP3833668B1 (fr) 2018-08-07 2025-03-19 Merck Sharp & Dohme LLC Inhibiteurs de prmt5
CA3108388A1 (fr) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5
EP3833667B1 (fr) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Inhibiteurs de prmt5
WO2020033285A1 (fr) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5
WO2020036869A1 (fr) 2018-08-16 2020-02-20 Emd Millipore Corporation Dispositif de biotraitement fermé
EP4076460B1 (fr) 2019-12-17 2026-01-21 Merck Sharp & Dohme LLC Dérivés de 1,4-dihydro-2h-spiro[isoquinoline-3,4'-piperidine] en tant qu'inhibiteurs de prmt5 pour le traitement du cancer
WO2021126728A1 (fr) 2019-12-17 2021-06-24 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5
JP7589247B2 (ja) 2019-12-17 2024-11-25 メルク・シャープ・アンド・ドーム・エルエルシー Ｐｒｍｔ５阻害剤
WO2026027944A1 (fr) 2024-07-30 2026-02-05 Sairopa B.V. Formulations d'anticorps anti-sirp alpha et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057342A (en) * 1996-08-16 2000-05-02 Dupont Pharmaceutical Co. Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
US6440686B1 (en) * 2000-06-15 2002-08-27 Cytokinetics, Inc. Methods for screening and therapeutic applications of kinesin modulators
WO2003049527A2 (fr) * 2001-12-06 2003-06-19 Merck & Co., Inc. Inhibiteurs miotitiques de la kinesine
KR20050010515A (ko) * 2002-06-14 2005-01-27 머크 앤드 캄파니 인코포레이티드 유사분열 키네신 억제제
US7301028B2 (en) * 2002-06-14 2007-11-27 Merck & Co., Inc. Mitotic kinesin inhibitors
AU2003287057B2 (en) * 2002-10-18 2008-08-21 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors

Also Published As

Publication number Publication date
US20050038074A1 (en) 2005-02-17
AR045342A1 (es) 2005-10-26
ECSP066362A (es) 2006-10-31
TW200510380A (en) 2005-03-16
IS8276A (is) 2006-01-31
PE20050730A1 (es) 2005-09-20
CO5650252A2 (es) 2006-06-30
NO20061194L (no) 2006-05-05
KR20060058716A (ko) 2006-05-30
WO2005019205A1 (fr) 2005-03-03
IL173513A0 (en) 2006-07-05
BRPI0413580A (pt) 2006-10-17

Similar Documents

Publication Publication Date Title
MA27986A1 (fr) Inhibiteurs de kinesine mitotique
DE602004010791D1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
DE60228212D1 (de) Neue expressionsvektoren
AP2005003220A0 (en) Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.
CY1116649T1 (el) Τεχνητη dna αλληλουχια με βελτιστοποιημενη λειτουργια οδηγου σε 5&#39; (5-utr) για βελτιωμενη εκφραση ετερολογων πρωτεϊνων σε φυτα
DE50310579D1 (de) Furancarboxamide
ATE460938T1 (de) Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
ATE374212T1 (de) Neue kalium-kanäle und dafür kodierende gene
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
ATE327987T1 (de) Methylthiophencarboxanilide
DE50308032D1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
TW200716177A (en) Isolated photoprotein aqdecay, and its use
DE60129206D1 (de) Verfahren zur erhöhung der genexpression der transfizierten genen
WO2005000202A3 (fr) Compositions et methodes de modulation de l&#39;expression de la proteine b7
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ES1056659Y (es) Carterita portadora de mondadientes.
ITMI20031077A1 (it) Autocattura antisoffocamento silenziosa, per bovini.
AU2003262177A8 (en) Insecticide proteins from photorabdus luminescens
AU2003285020A8 (en) Modified nucleotide sequence encoding c. albicans khc kinesin protein
ITFI20030170A1 (it) Diffusore per aeratori sommersi.
TW200716666A (en) Isolated photoprotein gr-bolinopsin, and its use